New Bandage-Like matrix could speed healing after skin cancer removal

NCT ID NCT06578650

Recruiting now Disease control Sponsor: Acera Surgical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a synthetic fiber matrix called Restrata, placed directly into surgical wounds after skin cancer removal. Researchers will track how long it takes for the wound bed to granulate (fill in with new tissue) and fully heal. The trial enrolls 34 adults with wounds between 4 and 36 square centimeters.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Synthetic electrospun fiber matrix (Restrata)
What this could lead to: If it works, this could provide a faster, more effective way to heal wounds after skin cancer surgery, reducing recovery time and complications.
What could go wrong: This is a small, early-stage trial with only 34 participants and no comparison group, so results may not apply to everyone. The device may not improve healing over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT CUTANEOUS NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin cancer Surgical Wound

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SURGICAL WOUND

Contacts and locations

Locations

University Nevada - Las Vegas
RECRUITING

Las Vegas, Nevada, 89102, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.